Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1963 1
1990 1
2009 1
2010 1
2011 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Esophageal dysmotility associated with systemic sclerosis: a high-resolution manometry study.
Roman S, Hot A, Fabien N, Cordier JF, Miossec P, Ninet J, Mion F; Réseau Sclérodermie des Hospices Civils de Lyon. Roman S, et al. Dis Esophagus. 2011 Jul;24(5):299-304. doi: 10.1111/j.1442-2050.2010.01150.x. Epub 2010 Dec 17. Dis Esophagus. 2011. PMID: 21166734
Esophageal symptoms encountered in 87.5% of patients were not predictive of esophageal dysmotility. This HRM series confirms the high prevalence of esophageal body dysmotility in systemic sclerosis. Diffuse skin involvement, positive Scl70 and negative …
Esophageal symptoms encountered in 87.5% of patients were not predictive of esophageal dysmotility. This HRM series confirms the high …
Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis.
Rose RF, Turner D, Goodfield MJ, Goulden V. Rose RF, et al. Photodermatol Photoimmunol Photomed. 2009 Jun;25(3):153-5. doi: 10.1111/j.1600-0781.2009.00422.x. Photodermatol Photoimmunol Photomed. 2009. PMID: 19438995
We carried out a retrospective study to examine the effectiveness of UVA1 phototherapy in scleroderma affecting acral and proximal sites in patients with this disease. Patients with systemic sclerosis (diffuse type, n=5; limited type, n=3) underwent low-dose …
We carried out a retrospective study to examine the effectiveness of UVA1 phototherapy in scleroderma affecting acral and proximal sites in …
Penicillamine in systemic sclerosis: a reappraisal.
Sattar MA, Guindi RT, Sugathan TN. Sattar MA, et al. Clin Rheumatol. 1990 Dec;9(4):517-22. doi: 10.1007/BF02030514. Clin Rheumatol. 1990. PMID: 2088649
In a 36-month prospective trial 21 patients with systemic sclerosis (diffuse systemic sclerosis 16 patients and 5 subjects with limited cutaneous subtype) were treated with D-penicillamine. ...The degree and extent of skin involvement decreased significantly …
In a 36-month prospective trial 21 patients with systemic sclerosis (diffuse systemic sclerosis 16 patients and 5 subje …